Syncell is a life science technology company building products for next-generation spatial biology. Its pioneering Microscoop™ technology enables microscopy-guided nanoscale protein "scooping", making unbiased subcellular spatial biomarker discovery feasible for the first time. This spatial proteomics technology is applicable to a broad scope of biological problems to help understand molecular mechanisms, identify novel disease biomarkers, and reveal novel druggable targets. It has been used to enable the discovery of novel protein constituents in beta amyloids associated with Alzheimer's disease, TDP-43 aggregates associated with ALS disease, a marker of triple negative breast cancer, etc.